Stockreport

Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer [Yahoo! Finance]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF On Monday, Protagonist Therapeutics, Inc. (NASDAQ: PTGX ) and Takeda Pharmaceutical Co Ltd (NYSE: TAK ) released topline results for the Phase 3 VERIFY study of rusfert [Read more]